Rolina Al-Wassia1, Houda Bahig2, Emily Poon3, William Parker4, Carolyn Freeman2. 1. Department of Oncology, Division of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada; King Abdulaziz University, Jeddah, Saudi Arabia. 2. Department of Oncology, Division of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada. 3. Department of Medical Physics, McGill University Health Centre, Montreal, Quebec, Canada. 4. Department of Medical Physics, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: William.parker@mcgill.ca.
Abstract
PURPOSE: Setup deviations of a craniospinal irradiation (CSI) patient cohort previously treated with helical tomotherapy were used to derive the optimal planning target volume (PTV) margin for CSI patients treated in the supine position. METHODS AND MATERIALS: The daily setup shifts of 27 CSI tomotherapy patients as determined using pretreatment megavoltage computed tomography verification for a total of 454 fractions were evaluated. Translational displacements in the mediolateral (ML), craniocaudal (CC), and anteroposterior (AP) directions were used to assess the systematic and random setup errors, and to derive the PTV margin required when daily image guidance is unavailable. RESULTS: The individual patient mean shifts and the corresponding standard deviations in the ML, CC, and AP directions were -0.5 ± 2.1 mm, 1.0 ± 2.7 mm, and 0.7 ± 1.1 mm, respectively. The random errors in the corresponding directions were 1.9 mm, 1.9 mm, and 2.2 mm. The PTV margins required in the absence of daily imaging were 3.7 mm to the right, 4.7 mm to the left, 4.4 mm inferior, 6.4 mm superior, 1.6 mm posterior, and 3.0 mm anterior. CONCLUSIONS: The current PTV margin of 3.0 mm is sufficient to ensure clinical target volume coverage for CSI tomotherapy patients treated with daily megavoltage computed tomography imaging. When pretreatment verification imaging is not used to lower the setup uncertainty, a larger PTV margin of up to 6.4 mm in the CC direction will be needed.
PURPOSE: Setup deviations of a craniospinal irradiation (CSI) patient cohort previously treated with helical tomotherapy were used to derive the optimal planning target volume (PTV) margin for CSI patients treated in the supine position. METHODS AND MATERIALS: The daily setup shifts of 27 CSI tomotherapy patients as determined using pretreatment megavoltage computed tomography verification for a total of 454 fractions were evaluated. Translational displacements in the mediolateral (ML), craniocaudal (CC), and anteroposterior (AP) directions were used to assess the systematic and random setup errors, and to derive the PTV margin required when daily image guidance is unavailable. RESULTS: The individual patient mean shifts and the corresponding standard deviations in the ML, CC, and AP directions were -0.5 ± 2.1 mm, 1.0 ± 2.7 mm, and 0.7 ± 1.1 mm, respectively. The random errors in the corresponding directions were 1.9 mm, 1.9 mm, and 2.2 mm. The PTV margins required in the absence of daily imaging were 3.7 mm to the right, 4.7 mm to the left, 4.4 mm inferior, 6.4 mm superior, 1.6 mm posterior, and 3.0 mm anterior. CONCLUSIONS: The current PTV margin of 3.0 mm is sufficient to ensure clinical target volume coverage for CSI tomotherapy patients treated with daily megavoltage computed tomography imaging. When pretreatment verification imaging is not used to lower the setup uncertainty, a larger PTV margin of up to 6.4 mm in the CC direction will be needed.
Authors: Daniel Gram; André Haraldsson; N Patrik Brodin; Karsten Nysom; Thomas Björk-Eriksson; Per Munck Af Rosenschöld Journal: Radiat Oncol Date: 2020-06-10 Impact factor: 3.481
Authors: Jennifer Novak; Dongsu Du; Ashwin Shinde; Richard Li; Arya Amini; Yi-Jen Chen; Jeffrey Wong; Chunhui Han; John Neylon; An Liu; Scott Glaser Journal: Adv Radiat Oncol Date: 2021-07-04